In parnership with
About Thoracic Oncology Frontiers
An international multidisciplinary event bridging translational research and clinical medicine, this meeting will convene global leaders across thoracic oncology to improve MDT decision making and accelerate translation of trial evidence into real-world practice.
This two day international conference will bring together leaders across the thoracic oncology pathway to explore advances in:
- Multimodal treatment strategies
- Neoadjuvant & perioperative therapy
- Radiotherapy integration
- Surgical innovation
- Molecular selection
- Imaging & response assessment
- Oligometastatic disease
The meeting aims to improve MDT decision-making, explore sequencing of therapies and translate trial evidence into real-world pathways.
This conference is designed for professionals involved across the thoracic oncology pathway, including medical oncologists, clinical and radiation oncologists, thoracic surgeons, respiratory physicians, radiologists, pathologists, research leaders, nursing and allied health professionals, and guideline contributors.
Who is the Thoracic Oncology Frontiers for?
This conference is designed for professionals involved across the thoracic oncology pathway, including medical oncologists, clinical and radiation oncologists, thoracic surgeons, respiratory physicians, radiologists, pathologists, research leaders, nursing and allied health professionals, and guideline contributors.
Key Speakers
Dr Sean Dulloo (Chair)
Dr Sean Dulloo is a Consultant Medical Oncologist & Honorary Associate Professor at the University Hospitals of Leicester NHS Trust and University of Leicester. Dr. Dulloo is the current Head of Service for Oncology and clinical lead for thoracic oncology. Dr Dulloo completed his Internal Medicine residency at the National University Health System, Singapore. He completed his Oncology training at Leicester and also successfully completed his higher research degree (MD) during this time focussing on Epithelial Mesenchymal Transition in mesothelioma.
Dr Dulloo serves as a Chief and Principal Investigator in various international clinical trials including early phase trials. His work focuses on innovative treatments for pleural mesothelioma and lung cancer. He has also presented his work at major conferences. He has published widely in high impact journals including Nature.
Event Venue
Leicester Marriott
Address: Grove Park, Smith Way, Enderby, Leicester, LE19 1SW, UK
Accommodation: Conference delegates can book their own overnight accomodation directly with the Marriott Leicester.
To book overnight accommodation: More details to follow up shortly.
